AVROBIO Inc. Launches to Develop Novel, Clinical-Stage Cell and Gene Therapies Targeting Immuno-Oncology and Rare Diseases Disruptive Therapies with Potential to Displace Standard of Care Treatments for Acute Myeloid Leu

First Page		Document Content
Date: 2016-02-18 12:07:01 Biotechnology University of Toronto Emerging technologies Induced stem cells Stem cells Gene therapy University Health Network Toronto Western Research Institute Krembil Research Institute		AVROBIO Inc. Launches to Develop Novel, Clinical-Stage Cell and Gene Therapies Targeting Immuno-Oncology and Rare Diseases Disruptive Therapies with Potential to Displace Standard of Care Treatments for Acute Myeloid Leu Add to Reading List Source URL: www.ccrm.ca Download Document from Source Website File Size: 223,64 KB Share Document on Facebook

	261 Special Issue on MOOCs Bali /JOGLTEP, ), Journal of Global Literacies, Technologies, and Emerging Pedagogies Volume 2, Issue 3, July 2014, ppGoing beyond the good MOOC/bad MOOC debate DocID: 1xVqF - View Document
	EMERGING TECHNOLOGIES AND THE GEOSPATIAL DocID: 1vogE - View Document
	PREPRINT: "H. Kashif, J. J. Thomas, H. Patel, and S. Fischmeister, "Static slack-based instrumentation of programs," in 20th IEEE Conference on Emerging Technologies \\& Factory Automation, ETFA, 2015, pp. 1-8." Static S DocID: 1vnYl - View Document
	RESOLUTION OF THE BOARD OF TRUSTEES OF THE AMERICAN PILOTS’ ASSOCIATION October 18, 2017 EMERGING ELECTRONIC NAVIGATION AND CONTROL TECHNOLOGIES DocID: 1vnbd - View Document
	Emerging Technologies & Factory Automation DocID: 1vhus - View Document